Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lauren Hertan, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yerramilli D, Parker G, LeBaron V, Krishnan M, Hertan L, Spektor A, Shiloh R, Skamene S, Balboni T. Ethical issues in patients referred for palliative radiation therapy. Ann Palliat Med. 2019 07; 8(3):231-239. PMID: 31370662.
    Citations:    
  2. Shi DD, Hertan LM, Lam TC, Skamene S, Chi JH, Groff M, Cho CH, Ferrone ML, Harris M, Chen YH, Balboni TA. Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e285-e294. PMID: 29703703.
    Citations:    Fields:    Translation:Humans
  3. Dharmarajan KV, Rich SE, Johnstone CA, Hertan LM, Wei R, Colbert LE, Jones JA, Kamal AH, Jones CA. Top 10 Tips Palliative Care Clinicians Should Know About Radiation Oncology. J Palliat Med. 2018 03; 21(3):383-388. PMID: 29431573.
    Citations:    Fields:    
  4. Skamene S, Agarwal I, Makar M, Krishnan M, Spektor A, Hertan L, Mouw KW, Taylor A, Noveroske Philbrick S, Balboni T. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases. Ann Palliat Med. 2018 Apr; 7(2):186-191. PMID: 29307209.
    Citations:    Fields:    Translation:Humans
  5. Shi DD, Chen YH, Lam TC, Leonard D, Balboni TA, Schoenfeld A, Skamene S, Cagney DN, Chi JH, Cho CH, Harris M, Ferrone ML, Hertan LM. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases. Spine J. 2018 06; 18(6):935-940. PMID: 29031992.
    Citations:    Fields:    
  6. Parker GM, LeBaron VT, Krishnan M, Shiloh RY, Spektor A, Hertan L, Balboni TA. Burden of palliative care issues encountered by radiation oncologists caring for patients with advanced cancer. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):e517-e524. PMID: 28688910.
    Citations:    Fields:    Translation:Humans
  7. Evans T, Ciunci C, Hertan L, Gomez D. Special topics in immunotherapy and radiation therapy: reirradiation and palliation. Transl Lung Cancer Res. 2017 Apr; 6(2):119-130. PMID: 28529895.
    Citations: 1     
  8. Balboni TA, Braunstein SE, Fogh SE, Anderson W, Pantilat S, Taylor A, Spektor A, Krishnan MS, Haas-Kogan DA, Hertan LM. Acute pain management in radiation oncology: Quality of care and the impact of an integrated palliative oncology service. J Clin Oncol. 2016 Oct 09; 34(26_suppl):195. PMID: 28156446.
    Citations:    
  9. Hertan LM, Jones JA, Balboni TA. Palliative Radiation Oncology: Moving Beyond the Single Fraction. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):48-50. PMID: 26700701.
    Citations:    Fields:    Translation:Humans
  10. Forastiere AA, Flood WA, Whyler E, Hertan LM, Sharma S, Jones JA. Utilization of single-fraction radiotherapy for the treatment of bone metastases before and after the "Choosing Wisely" campaign. J Clin Oncol. 2014 Nov; 32(31_suppl):245. PMID: 28142738.
    Citations:    
  11. Sharma S, Hertan L, Jones J. Palliative radiotherapy: current status and future directions. Semin Oncol. 2014 Dec; 41(6):751-63. PMID: 25499634.
    Citations: 3     Fields:    Translation:HumansAnimals
  12. Hertan L, Jones JA. Palliative radiotherapy for prostate cancer: encouraging single-fraction radiotherapy. Oncology (Williston Park). 2014 Apr; 28(4):317-8. PMID: 24839804.
    Citations:    Fields:    Translation:Humans
  13. Tuttle S, Hertan L, Daurio N, Porter S, Kaushick C, Li D, Myamoto S, Lin A, O'Malley BW, Koumenis C. The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. . 2012 May; 13(7):575-84. PMID: 22441776.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  14. Lin LL, Hertan L, Rengan R, Teo BK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):670-5. PMID: 22208974.
    Citations: 10     Fields:    Translation:Humans
  15. Tuttle S, Hertan L, Katz JS. Indian gold treating cancer in the age of nano. . 2011 Mar 01; 11(5):474-6. PMID: 21263231.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  16. Javvadi P, Hertan L, Kosoff R, Datta T, Kolev J, Mick R, Tuttle SW, Koumenis C. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res. 2010 Mar 01; 70(5):1941-50. PMID: 20160040.
    Citations: 11     Fields:    Translation:HumansCells
  17. Hertan LM, Koumenis C. Piling up the JNK: drug synergy through ER stress. . 2009 May; 8(9):820-2. PMID: 19458484.
    Citations: 1     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hertan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (96)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.